Skip to main content
. 2010 Oct 14;10:555. doi: 10.1186/1471-2407-10-555

Figure 3.

Figure 3

Schematic representation of the putative complexes formed by mSMO with the substrate Spm (A), the inhibitor MDL 72527 (B), and the analogues BENSpm (C) and CPENSpm (D). For details see Methods section.